121 related articles for article (PubMed ID: 266949)
1. Analysis of treatment in childhood leukaemia. III. Independence of lymphopenia induced by irradiation and by chemotherapy.
Waller CA; MacLennan IC; Campbell AC; Festenstein M; Kay HE
Br J Haematol; 1977 Apr; 35(4):597-612. PubMed ID: 266949
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive consequences of radiotherapy and chemotherapy in patients with acute lymphoblastic leukaemia.
Campbell AC; Hersey P; MacLennan IC; Kay HE; Pike MC
Br Med J; 1973 May; 2(5863):385-8. PubMed ID: 4574043
[TBL] [Abstract][Full Text] [Related]
3. Analysis of treatment in childhood leukemia. IV. The critical association between dose fractionation and immunosuppression induced by cranial irradiation.
MacLennan IC; Kay HE
Cancer; 1978 Jan; 41(1):108-11. PubMed ID: 272224
[TBL] [Abstract][Full Text] [Related]
4. Analysis of treatment in childhood leukaemia. II. Timing and the toxicity of combined 6-mercaptopurine and methotrexate maintenance therapy.
MacLennan IC; Kay HE; Festenstein M; Smith PG
Br J Haematol; 1976 Jun; 33(2):179-88. PubMed ID: 1063593
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression and immunostimulation in acute leukaemia.
MacLennan CM
Proc R Soc Med; 1975 Apr; 68(4):216-7. PubMed ID: 1060147
[No Abstract] [Full Text] [Related]
6. Glioblastoma multiforme following prophylactic cranial irradiation and intrathecal methotrexate in a child with acute lymphoblastic leukaemia : a case report.
Muzumdar DP; Desai K; Goel A
Neurol India; 1999 Jun; 47(2):142-4. PubMed ID: 10402343
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression and serious infections in children with acute lymphoblastic leukaemia: a comparison of three chemotherapy regimes.
Rapson NT; Cornbleet MA; Chessells JM; Bennett AJ; Hardisty RM
Br J Haematol; 1980 May; 45(1):41-52. PubMed ID: 6929706
[TBL] [Abstract][Full Text] [Related]
8. Analysis of treatment in childhood leukaemia. I. Predisposition to methotrexate-induced neutropenia after craniospinal irradiation. Report to the Medical Research Council of the Working Party on Leukaemia in Childhood.
Br Med J; 1975 Sep; 3(5983):563-6. PubMed ID: 1100179
[TBL] [Abstract][Full Text] [Related]
9. Organ irradiation and combination chemotherapy in treatment of acute lymphocytic leukaemia in children.
Lanzkowsky P; Shende A; Aral I; Saluja G
Arch Dis Child; 1975 Sep; 50(9):685-90. PubMed ID: 1059384
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen ((Concord trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood.
Br Med J; 1971 Oct; 4(5781):189-94. PubMed ID: 4940157
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia.
Aur RJ; Simone JV; Hustu HO; Verzosa MS
Cancer; 1972 Feb; 29(2):381-91. PubMed ID: 4501697
[No Abstract] [Full Text] [Related]
12. Pyoderma gangrenosum in acute myeloid leukaemia during immunosuppression.
van de Kerkhof PC; de Vaan GA; Holland R
Eur J Pediatr; 1988 Oct; 148(1):34-6. PubMed ID: 3197731
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group.
Koizumi S; Fujimoto T; Takeda T; Yatabe M; Utsumi J; Mimaya J; Ninomiya T; Yanai M
Cancer; 1988 Apr; 61(7):1292-300. PubMed ID: 3278798
[TBL] [Abstract][Full Text] [Related]
14. High incidence of secondary brain tumours after radiotherapy and antimetabolites.
Relling MV; Rubnitz JE; Rivera GK; Boyett JM; Hancock ML; Felix CA; Kun LE; Walter AW; Evans WE; Pui CH
Lancet; 1999 Jul; 354(9172):34-9. PubMed ID: 10406363
[TBL] [Abstract][Full Text] [Related]
15. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
[TBL] [Abstract][Full Text] [Related]
16. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
[TBL] [Abstract][Full Text] [Related]
17. The incidence of B cell leukaemia and lymphopenia in B cell neoplasia in adults: a study using the Kiel classification of non-Hodgkin's lymphoma.
Cader A; Richardson P; Walsh L; Ling NR; MacLennan IC; Jones EL; Leyland M
Br J Cancer; 1983 Aug; 48(2):185-93. PubMed ID: 6603860
[TBL] [Abstract][Full Text] [Related]
18. Cured of acute lymphoblastic leukaemia but lost for words.
Winter E; Prendergast M
Neuropediatrics; 1995 Oct; 26(5):267-9. PubMed ID: 8552219
[TBL] [Abstract][Full Text] [Related]
19. Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
Chessells JM; Durrant J; Hardy RM; Richards S
J Clin Oncol; 1986 Dec; 4(12):1758-64. PubMed ID: 3537216
[TBL] [Abstract][Full Text] [Related]
20. Effect of polymorphisms in transporter genes on dosing, efficacy and toxicity of maintenance therapy in children with acute lymphoblastic leukemia.
Gervasini G; de Murillo SG; Jiménez M; de la Maya MD; Vagace JM
Gene; 2017 Sep; 628():72-77. PubMed ID: 28710036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
